US drug sales growth continues slowdown in 2008

Mar 19, 2009

(AP) -- Sales growth of prescription drugs in the U.S. slowed for the second straight year, with the economic downturn playing a key role, according to IMS Health Inc.

Market research firm IMS cites lower demand for less-expensive generic drugs, lagging new product , and reduced consumer demand. Sales rose just 1.3 percent to $291 billion in 2008. That about matches IMS' prior outlook of 1 percent to 2 percent growth.

In 2007, U.S. sales rose 3.8 percent to $286.5 billion, while they gained 8 percent in 2006.

Anti-psychotic drugs were the lead sales drivers, followed by and treatments for heartburn and related conditions.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Combining epilepsy drug, morphine can result in less pain, lower opioid doses

add to favorites email to friend print save as pdf

Related Stories

World semiconductor sales up 5 percent

Nov 01, 2005

World semiconductor sales grew more than 5 percent in September as demand remained robust and driven by brisk markets for cell phones and personal computers.

Semiconductor sales down 28.6 pct in January: SIA

Mar 02, 2009

Worldwide semiconductor sales declined 28.6 percent in January from a year ago as the global recession continued to take a big bite out of the computer chip industry, an industry tracker said Monday.

Recommended for you

Vaccine proves effective against deadly Middle East virus

19 hours ago

(Medical Xpress)—A vaccine developed by an international team of scientists led by the University of Pittsburgh School of Medicine successfully protects mice against a contagious and deadly virus spreading across the Middle ...

New study looks at improving vaccine awareness

21 hours ago

The best medical therapies won't do much good if the public abstains from using them. Resistance to life-saving interventions may have a variety of root causes, particularly if the biotechnology involved is new and poorly ...

High-dose opioid prescribing continues to climb

Sep 12, 2014

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new ...

Feds say Bayer colon supplement makes bogus claims

Sep 12, 2014

The United States government accused Bayer of making scientifically unproven statements about the health benefits of a popular probiotic on Friday, claiming the German pharmaceutical giant was in contempt of court.

User comments : 0